+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

DNA-Encoded Libraries: Platforms and Services Market - Product Thumbnail Image

DNA-Encoded Libraries: Platforms and Services Market

  • Report
  • January 2019
  • 133 Pages
  • Global
From
Prescription Drugs Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Prescription Drugs Market - Forecasts from 2022 to 2027

  • Report
  • September 2022
  • 155 Pages
  • Global
From
Small Molecule API Market Report and Forecast 2024-2032 - Product Thumbnail Image

Small Molecule API Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 160 Pages
  • Global
From
Cell and Gene Therapy Market 2022-2026 - Product Thumbnail Image

Cell and Gene Therapy Market 2022-2026

  • Report
  • September 2022
  • 120 Pages
  • Global
From
From
Precision Medicine Market Report and Forecast 2023-2031 - Product Thumbnail Image

Precision Medicine Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
From
From
Markets at a Glance: Pharmaceuticals - Product Thumbnail Image

Markets at a Glance: Pharmaceuticals

  • Report
  • May 2019
  • 115 Pages
  • Global
From
Cancer Therapeutics Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cancer Therapeutics Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Loading Indicator